로딩 중…
지수 로딩 중…
제노레이
122310· KOSDAQ· Health Care· Health Care Equipment & Services
₩3,340-3.75%
2026-06-19
Price Chart
제노레이-42.81%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 48.61B KRW |
| Revenue | 108.27B KRW |
| Net Income | 2.85B KRW |
| Total Assets | 136.52B KRW |
| Net Assets | 82.60B KRW |
| Employees | 358 |
| Value | |
| P/E | 17.09x |
| P/B | 0.59x |
| P/S | 0.45x |
| FCF Yield | 8.14% |
| Profitability | |
| ROE | 3.44% |
| ROA | 2.08% |
| Op. Margin | -0.25% |
| Revenue Growth | 0.90% |
| Earnings Growth | -428.04% |
| Financial Health | |
| Debt Ratio | 165.26% |
| Total Debt | 26.47B KRW |
| FCF | 3.96B KRW |
| Cash | 11.41B KRW |
| Current Ratio | 1.94x |
| Dividend | |
| Div. Yield | 4.32% |
| Div. Growth | -16.67% |
| Performance | |
| 1Y Return | -42.81% |
| 1M Return | -28.48% |
| From 52W High | -46.90% |
| 1Y MDD | -43.20% |
| Trading | |
| Volume | 29,629 shares |
| Foreign Own. | 1.30% |
| Per Share | |
| EPS | 15 KRW |
| BPS | 6,548 KRW |
Company Info
Established in 2001 and listed on KOSDAQ in 2018, the company maintains overseas branches in the United States, Germany, Japan, Türkiye, and China. It researches, develops, manufactures, and sells X-ray diagnostic equipment for hospital and dental medical environments, uniquely operating in both medical and dental sectors domestically. Leveraging its proprietary Complementary Metal-Oxide-Semiconductor Flat Panel Detector (CMOS FPD) sensor development and manufacturing technology, the company achieves cost competitiveness and high quality. It internalizes operations from R&D to sales to meet market demands. Genoray is headquartered in Seongnam-si, Gyeonggi-do.